CRISPR Therapeutics AG Reports Q2 Revenue $10.2M, vs. FactSet Est of $7.4M MT Aug. 03 CRISPR Therapeutics AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI Jun.

Gene-edited banana by Tropic Biosciences clears England's first regulatory hurdle, showing 30% less browning, but FSA ...

Analysts aren't deterred though, including Citi 's Yigal Nochomovitz, who recently raised his price target on CRSPR from $82 to $88 per share on growing demand for the aforementioned Casgevy. That's ...

A team of biochemists at the University of Minnesota (UMN) accidentally discovered that a single bacterial DNA repair gene ...

CRISPR-Cas9 removed an extra chromosome 21 from some Down syndrome cells in the lab. Learn what the 30.6% result means and ...

For decades, scientists have believed that a protein called interferon tau (IFNT) is indispensable for pregnancy in cattle.

LMU researchers challenge a decades-old model: genetically modified embryos lacking interferon tau can establish pregnancies and develop into healthy ...

CRISPR-generated knockout mutants reveal that the highly expressed, symbiosome-localized nodulin NOD25 is dispensable for ...

Researchers have used CRISPR-Cas9 to remove CD28 from donor T cells and prevent fratricide before equipping them with ...

Fintel reports that on October 8, 2026, Wells Fargo upgraded their outlook for Editas Medicine (NASDAQGS:EDIT) (LSE:0IFK) from Equal-Weight to Overweight. Editas Medicine, Inc., based in the United ...

DNA typewriter maps mouse embryo development to reveal disease origins Barcode trail tracks cell family trees to pinpoint ...